(Total Views: 149)
Posted On: 06/15/2021 2:48:50 PM
Post# of 18401
$IKT News : Inhibikase Therapeutics to Present at Upcoming Jefferies Virtual Healthcare Conference & Others
ATLANTA, May 25, 2021 /PRNewswire/ -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase), a clinical-stage pharmaceutical company developing therapeutics to modify the course of Parkinson's disease and related disorders inside and outside of the brain, today announced that Dr. Milton Werner, Ph.D., Chief Executive Officer of Inhibikase, will present at the Jefferies Virtual Healthcare Conference:
https://finance.yahoo.com/news/inhibikase-the...00040.html
ATLANTA, May 25, 2021 /PRNewswire/ -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase), a clinical-stage pharmaceutical company developing therapeutics to modify the course of Parkinson's disease and related disorders inside and outside of the brain, today announced that Dr. Milton Werner, Ph.D., Chief Executive Officer of Inhibikase, will present at the Jefferies Virtual Healthcare Conference:
https://finance.yahoo.com/news/inhibikase-the...00040.html
(0)
(0)
